共 50 条
Wnt signaling pathway and sclerostin in the development of atherosclerosis and vascular calcification
被引:3
作者:
Kocelak, Piotr
[1
]
Puzianowska-Kuznicka, Monika
[2
,3
]
Olszanecka-Glinianowicz, Magdalena
[4
]
Chudek, Jerzy
[5
]
机构:
[1] Med Univ Silesia, Fac Med Sci, Dept Pathophysiol, Pathophysiol Unit, Katowice, Poland
[2] Med Ctr Postgrad Educ, Dept Geriatr & Gerontol, Warsaw, Poland
[3] Polish Acad Sci, Mossakowski Med Res Inst, Dept Human Epigenet, PL-02106 Warsaw, Poland
[4] Med Univ Silesiaia, Fac Med Sci Katowice, Dept Pathophysiol, Hlth Promot & Obes Management Unit, PL-40055 Katowice, Poland
[5] Med Univ Silesia, Fac Med Sci Katowice, Dept Internal Med & Oncol Chemotherapy, Katowice, Poland
来源:
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE
|
2024年
/
33卷
/
05期
关键词:
atherosclerosis;
aneurysm;
cardiovascular disease;
sclerostin;
WNT-signaling;
SMOOTH-MUSCLE-CELLS;
BONE-MINERAL DENSITY;
WNT/BETA-CATENIN;
POSTMENOPAUSAL WOMEN;
SERUM SCLEROSTIN;
CIRCULATING SCLEROSTIN;
AORTIC-ANEURYSM;
KIDNEY-DISEASE;
OSTEOBLAST DIFFERENTIATION;
CONVERGENT EXTENSION;
D O I:
10.17219/acem/169567
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Atherosclerosis is a complex process involving endothelial dysfunction, vascular inflammation, vascular smooth muscle cell (VSMC) proliferation, angiogenesis, and calcification. One of the pathomechanisms of atherosclerosis is the upregulation of Wnt signaling. This study aimed to summarize the current knowledge regarding the role of Wnt signaling and sclerostin in atherosclerosis, vascular calcification, aneurysms, and mortality based on the PubMed database. We followed the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) recommendation and identified 160 papers that were included in this systematic review. The published data highlight that the upregulation of Wnt components facilitates the initiation and progression of atherosclerosis, arterial remodeling, VSMCs proliferation and phenotypic transition to the osteoblastic lineage in the arterial wall. This results in protein secretion, cell migration, calcification, fibrosis and aneurysm formation. The transformation of VSMCs into osteoblast-like cells that is observed in atherosclerosis results in sclerostin expression inhibiting the Wnt pathway. Furthermore, it was shown that sclerostin, expressed in atherosclerotic plaques, inhibits aneurysm formation in a mouse model. However, in humans, while the antisclerostin antibody romosozumab inhibits bone resorption, biochemical parameters of endothelial activation and inflammation are not affected, and the incidence of aneurysms is not increased. It was suggested that detecting sclerostin in the calcified aortic atherosclerotic plaques reflects a defense mechanism against Wnt activation and inhibition of atherosclerosis, although this has only been shown in animal models. Moreover, an increased number of vascular cells converted to osteogenic phenotypes results in increased plasma sclerostin concentrations. Therefore, plasma sclerostin derived from bone limits its importance as a global marker of vascular calcification.
引用
收藏
页码:519 / 532
页数:14
相关论文
共 50 条